Results 31 to 40 of about 154,650 (346)

Omalizumab-Associated Steatohepatitis

open access: yesActas Dermo-Sifiliográficas, 2023
Article disponible en castellà: http://hdl.handle.net/10230 ...
Barbosa, Joana   +3 more
openaire   +4 more sources

Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes, but not with insulin resistance [PDF]

open access: yes, 2014
Mice lacking transcription factor NF-E2 p45-related factor 2 (Nrf2) develop more severe non-alcoholic steatohepatitis (NASH), with cirrhosis, than wild-type (Nrf2(+/+)) mice when fed a high-fat (HF) diet for 24 weeks.
Chowdhry, Sudhir   +19 more
core   +1 more source

Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial

open access: yesNature Medicine, 2023
The FLIGHT-FXR trial, testing farnesoid X receptor agonist tropifexor in nonalcoholic steatohepatitis, demonstrated sustained decreases in alanine aminotransferase levels and hepatic fat fraction, but not aspartate aminotransferase, with dose-dependent ...
A. Sanyal   +26 more
semanticscholar   +1 more source

Hepatitis C and Nonalcoholic Steatohepatitis in the 21st Century: Impact on Liver Disease and Liver Transplantation

open access: yesGastroenterology Insights, 2023
Hepatitis C infection is a leading etiology of hepatic dysfunction and a major indication for liver transplantation due to the development of fibrosis, cirrhosis, and hepatocellular carcinoma.
Sonia Samuel, Ahmad Abulawi, Raza Malik
doaj   +1 more source

Pyroptosis and gasdermins—Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis

open access: yesFrontiers in Cell and Developmental Biology, 2023
In recent years, there has been a rapid expansion in our understanding of regulated cell death, leading to the discovery of novel mechanisms that govern diverse cell death pathways.
Christian Stoess   +4 more
doaj   +1 more source

Non-alcoholic fatty liver disease: Definition and subtypes [PDF]

open access: yesClinical and Molecular Hepatology, 2023
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide, with a global prevalence of approximately 30%. However, the prevalence of NAFLD has been variously reported depending on the comorbidities.
Seul Ki Han   +2 more
doaj   +1 more source

Nonalcoholic Steatohepatitis with Improved Hepatic Fibrosis after Weight Reduction [PDF]

open access: yes, 2004
A 65-year-old woman was admitted to our hospital for an investigation of liver dysfunction. She had mild obesity with hyperlipidemia, but no history of alcohol abuse. Other known causes of liver dysfunction, such as viruses, autoimmunity and drug effects,
Eguchi, Katsumi   +9 more
core   +1 more source

Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol

open access: yesNature Communications, 2023
The interplay between western diet and gut microbiota drives the development of non-alcoholic fatty liver disease and its progression to non-alcoholic steatohepatitis.
Ming Yang   +10 more
semanticscholar   +1 more source

Intestinal peroxisome proliferator‐activated receptor α‐fatty acid‐binding protein 1 axis modulates nonalcoholic steatohepatitis

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Peroxisome proliferator‐activated receptor α (PPARα) regulates fatty acid transport and catabolism in liver. However, the role of intestinal PPARα in lipid homeostasis is largely unknown. Here, intestinal PPARα was examined for its modulation of obesity and NASH. Approach and Results Intestinal PPARα was activated and fatty
Tingting Yan   +22 more
wiley   +1 more source

Primary Biliary Cholangitis Unmasked in Metabolic Dysfunction-Associated Steatohepatitis: When a Correct Diagnosis Is Incomplete. [PDF]

open access: yesKaohsiung J Med Sci
The Kaohsiung Journal of Medical Sciences, EarlyView.
Cheng Y, Chuang YH, Bair MJ, Huang JF.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy